Publication | Closed Access
ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype
54
Citations
21
References
2014
Year
Better Clinical IndicatorBreast OncologyMedicinePathologyBreast CancerMolecular OncologyCd44+/cd24− PhenotypeCancer TreatmentCancer GeneticsOncologyCell BiologyCancer ResearchTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1